The board of directors of InnoCare Pharma Limited (the "Company") announced that Mr. Quanhong Yuan ("Mr. Yuan") has resigned as a non-executive Director with effect from March 31, 2022 due to his other personal commitments which require more of his dedication and time commitment. The Board further announced that Mr. Ming Jin ("Mr. Jin"), who currently serves as a partner in Beijing Hankang Venture Capital Management Co. Ltd. ("Hankang Capital"), has been appointed as a non-executive Director with effect from March 31, 2022.
Mr. Jin,
has been an investment director of Hankang Capital since
2017 and was promoted to managing director and partner thereof in 2018 and 2020, respectively.